Skip to Main Content

Paper Details

Genomics driven precision oncology in advanced biliary tract cancer improves survival.
Neoplasia
0
2023
BRAF, BRAF mutant, BTC, BTCs, Biliary tract cancers, CD73, FGFR2, KRAS, KRAS and BRAF mutant tumors, NT5E, RNA, advanced BTC tumors, advanced biliary tract cancer, gallbladder cancer, intrahepatic, perihilar, and distal cholangiocarcinoma, malignancies, patients, tumor and normal DNA, tumor transcriptome, tumors
Author NameAffiliation
Chandan Kumar-SinhaMichigan Center for Translational Pathology, University of Michigan ann arbor
Pankaj VatsMichigan Center for Translational Pathology, University of Michigan ann arbor
Pankaj VatsMichigan Center for Translational Pathology, University of Michigan ann arbor
Dan R RobinsonMichigan Center for Translational Pathology, University of Michigan ann arbor
Yi-Mi WuMichigan Center for Translational Pathology, University of Michigan ann arbor
Xuhong CaoMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan, USA Rogel Cancer Center, USA Howard Hughes Medical Institute
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan, USA Rogel Cancer Center, USA Howard Hughes Medical Institute
  • 1 - 8

Datasets

Release 1.2